US Bancorp’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.84K Buy
356
+56
+19% +$1.45K ﹤0.01% 3396
2025
Q4
$7.63K Sell
300
-146
-33% -$3.26K ﹤0.01% 3416
2025
Q3
$7.19K Buy
446
+10
+2% +$162 ﹤0.01% 3421
2025
Q2
$6.98K Sell
436
-1,184
-73% -$17.9K ﹤0.01% 3536
2025
Q1
$27.7K Sell
1,620
-137
-8% -$2.87K ﹤0.01% 3029
2024
Q4
$43.5K Buy
1,757
+58
+3% +$1.65K ﹤0.01% 2803
2024
Q3
$48.4K Sell
1,699
-596
-26% -$17.6K ﹤0.01% 2756
2024
Q2
$60.6K Sell
2,295
-241
-10% -$6.86K ﹤0.01% 2572
2024
Q1
$81.9K Sell
2,536
-531
-17% -$19.4K ﹤0.01% 2459
2023
Q4
$129K Buy
3,067
+77
+3% +$2.83K ﹤0.01% 2227
2023
Q3
$115K Buy
2,990
+31
+1% +$701 ﹤0.01% 2083
2023
Q2
$56.1K Sell
2,959
-43
-1% -$802 ﹤0.01% 2451
2023
Q1
$46.6K Buy
3,002
+43
+1% +$746 ﹤0.01% 2559
2022
Q4
$52.5K Buy
2,959
+1,582
+115% +$19.9K ﹤0.01% 2501
2022
Q3
$8K Buy
1,377
+731
+113% +$3.57K ﹤0.01% 3448
2022
Q2
$3K Buy
646
+11
+2% +$48 ﹤0.01% 3734
2022
Q1
$3K Sell
635
-302
-32% -$1.88K ﹤0.01% 3747
2021
Q4
$8K Sell
937
-115
-11% -$949 ﹤0.01% 3504
2021
Q3
$9K Buy
+1,052
New +$9.49K ﹤0.01% 3481

Other funds holding IMVT